Bipartisan federal legislation in the House and Senate would create new incentives for post-acute patients to receive rehabilitation and other post-hospital care at home rather than in a SNF.
Category: Investing
Medicare Open Enrollment: Trends Of 2021
One online health insurance consolidator, eHealth, has compiled some interesting trends in how this year’s Medicare enrollment is shaping up.
Pay Vaccine Mandate Fines, Take Tax Write-Off?
If people and companies start paying, are these fines and penalties tax deductible?
The tax law on deducting fines and penalties has been muddled for years, so Congress at the end of 2017 tried to cut back on which fines and penalties can be deducted.
Medicare Part B Premiums To Rise 14.5% In 2022, With Premiums For Highest-Income Couples Nearly $14,000 A Year
Some 7% of Medicare recipients pay income-related surcharges on their Part B premiums, and they’re up 14.5% for 2022.
Moderna Crash Wipes Out Another $24 Billion After Supply Chain Issues Dent Covid Vaccine Sales
Now trading at their lowest level in three months, Moderna shares have struggled as experts question the long-term viability of the firm’s Covid-19 vaccine sales.
VC Firm 11.2 Capital Raises $101 Million To Back More ‘Deep Tech’ Companies Like Ginkgo Bioworks And Hinge Health
Las Vegas-based Shelley Zhuang was an early investor in Cruise, Ginkgo Bioworks and Hinge Health. Now she has $101,010,101 for a second “deep tech” fund.
China Adds New Billionaire Couple From Medical Industry
China is home to the world’s largest number of billionaires after the United States
“AI 2041” Co-Author Kai-Fu Lee Talks About AI’s Sweeping Future And How He Invests In It
Healthcare, manufacturing, transportation facing change
What Are States Doing With New Federal Funding For Medicaid Home-Based Long-Term Care?
When Congress increased the federal contribution to Medicaid’s home and community based care program by 10 percent or about $12 billion. What are governors doing with the money?
Moderna Crash Wipes Out $22 Billion In Value After Merck’s Covid Pill Triggers Vaccine Stock Plunge
Moderna tanked 15% Friday, while Novavax and BioNtech sank as much as 18%.
